{"id":176151,"date":"2022-03-01T00:00:00","date_gmt":"2022-02-28T23:00:00","guid":{"rendered":"https:\/\/www.bcfi.be\/covid-19-traitement-medicamenteux-precoce-de-la-covid-19-dans-le-contexte-ambulatoire-balises-belges\/"},"modified":"2026-04-02T19:10:17","modified_gmt":"2026-04-02T17:10:17","slug":"covid-19-traitement-medicamenteux-precoce-de-la-covid-19-dans-le-contexte-ambulatoire-balises-belges","status":"publish","type":"post","link":"https:\/\/h.cbip.be\/fr\/covid-19-traitement-medicamenteux-precoce-de-la-covid-19-dans-le-contexte-ambulatoire-balises-belges\/","title":{"rendered":"COVID-19: Traitement m\u00e9dicamenteux pr\u00e9coce de la COVID-19 dans le contexte ambulatoire : balises belges"},"content":{"rendered":"<p>La <a href='https:\/\/kce.fgov.be\/fr\/task-force-covid-therapeutics'><strong>Task Force belge \u00ab\u00a0COVID Therapeutics\u00a0\u00bb<\/strong><\/a> a publi\u00e9 le 25 f\u00e9vrier 2022 des <a href='https:\/\/kce.fgov.be\/sites\/default\/files\/atoms\/files\/BalisesCOVIDGP22022025-FR.pdf'><strong>Balises pour le traitement pr\u00e9coce ambulatoire des patients atteints d&#39;infection non s\u00e9v\u00e8re \u00e0 SARS-COV-2<\/strong><\/a>.<span class='folia-referentie-note'><strong><sup>1<\/sup><\/strong><\/span> Ce document&#x002C; qui se concentre sur le <strong>contexte ambulatoire<\/strong>&#x002C; fournit des <strong>avis concrets aux m\u00e9decins g\u00e9n\u00e9ralistes<\/strong>&#x002C; en s\u2019appuyant sur les preuves disponibles au sujet des m\u00e9dicaments (autoris\u00e9s ou en cours d&#39;\u00e9valuation) utilis\u00e9s chez les patients ambulatoires atteints de COVID-19. Des <strong>couleurs<\/strong> sont utilis\u00e9es pour sch\u00e9matiser la place des diff\u00e9rents m\u00e9dicaments. Le document propose un r\u00e9sum\u00e9 des donn\u00e9es probantes ; un rapport scientifique complet sera disponible bient\u00f4t. Les balises seront r\u00e9guli\u00e8rement mises \u00e0 jour.<br \/> Diverses organisations&#x002C; dont le CBIP&#x002C; ont collabor\u00e9 \u00e0 la r\u00e9alisation de ce document&#x002C; sous la coordination du KCE. Le CBIP vous tiendra au courant des mises \u00e0 jour publi\u00e9es.<br \/> \u00a0<\/p>\n<h2>Sources<\/h2>\n<div class='reference'><span class='folia-referentie-tekst'><span class='folia-referentie-nummer'>1.\u00a0<\/span> <a href='https:\/\/kce.fgov.be\/fr\/task-force-covid-therapeutics'><strong>Task Force \u201cCOVID Therapeutics\u201d<\/strong><\/a>: Balises pour le traitement m\u00e9dicamenteux du COVID-19 > Usage ambulatoire. Sur le <a href='https:\/\/kce.fgov.be\/fr\/balises-pour-le-traitement-m%C3%A9dicamenteux-du-covid-19'>site Web du KCE<\/a>&#x002C; ou directement sous format PDF: <a href='https:\/\/kce.fgov.be\/sites\/default\/files\/atoms\/files\/BalisesCOVIDGP22022025-FR.pdf'><strong>Balises pour le traitement pr\u00e9coce ambulatoire des patients atteints d&#39;infection non s\u00e9v\u00e8re \u00e0 SARS-COV-2<\/strong><\/a><\/span><\/div>\n","protected":false},"excerpt":{"rendered":"<p>La Task Force belge \u00ab\u00a0COVID Therapeutics\u00a0\u00bb a publi\u00e9 le 25  [&#8230;]<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12,40],"tags":[48,20213,20224,20226],"class_list":["post-176151","post","type-post","status-publish","format-standard","hentry","category-actualites","category-2022-fr","tag-actualites-covid-19","tag-import_tags","tag-import_tags-nl","tag-covid-19-update"],"_links":{"self":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts\/176151","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/comments?post=176151"}],"version-history":[{"count":1,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts\/176151\/revisions"}],"predecessor-version":[{"id":178732,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts\/176151\/revisions\/178732"}],"wp:attachment":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/media?parent=176151"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/categories?post=176151"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/tags?post=176151"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}